BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37878540)

  • 21. HLA-DR antigen-positive acute promyelocytic leukemia.
    Mendoza AS; Qing X; Dungo M; Lasky J; Panosyan E; Cai J
    Exp Mol Pathol; 2016 Oct; 101(2):197-200. PubMed ID: 27544027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunophenotypic Analysis of Acute Promyelocytic Leukemia].
    Chen F; Hu YP; Wang XH; Fu S; Fu Y; Liu X; Zhang MY; Wang SK; Zhang JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):321-5. PubMed ID: 27150985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using Antigen Expression of Leukemic Cells for a Fast Screening of Acute Promyelocytic Leukemia by Flow Cytometry.
    Ceni-Silva V; Pagnano K; Duarte G; Pellegrini M; Duarte B; Metze K; Lorand-Metze I
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia.
    Mosleh M; Mehrpouri M; Ghaffari S; Saei Z; Agaeipoor M; Jadali F; Satlsar ES; Gholampour R
    Scand J Clin Lab Invest; 2020; 80(2):87-92. PubMed ID: 31829759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CD9
    Ren F; Zhang N; Xu Z; Xu J; Zhang Y; Chen X; Tan Y; Chang J; Wang H
    Int J Lab Hematol; 2019 Apr; 41(2):168-175. PubMed ID: 30315692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia.
    Tran VT; Phan TT; Mac HP; Tran TT; Ho TT; Pho SP; Nguyen VN; Vo TM; Nguyen HT; Le TT; Vo TH; Nguyen ST
    BMC Res Notes; 2020 Aug; 13(1):394. PubMed ID: 32847610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of immunophenotypic analysis and molecular genetics in the diagnosis of acute promyelocytic leukemia].
    Gong JY; Li YY; Li CW; Wang YS; Liu Y; Wang C; Ru K; Mi YC; Wang JX; Wang HJ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Apr; 40(4):288-293. PubMed ID: 31104439
    [No Abstract]   [Full Text] [Related]  

  • 31. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
    Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
    Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities.
    Dong HY; Kung JX; Bhardwaj V; McGill J
    Am J Clin Pathol; 2011 Jan; 135(1):76-84. PubMed ID: 21173127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S; Ge Y; Li Z; Yang T
    Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia Using Flow Cytometry.
    Lewis JE; Cooper LAD; Jaye DL; Pozdnyakova O
    Mod Pathol; 2024 Jan; 37(1):100373. PubMed ID: 37925056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of bone marrow samples for discrimination of acute promyelocytic leukemia from other types of acute leukemia using the routine automated hematology analyzer.
    Jang MJ; Choi HW; Lee SY; Lee OJ; Kim HR; Shin JH; Suh SP; Ryang DW; Shin MG
    Int J Lab Hematol; 2014 Oct; 36(5):531-40. PubMed ID: 24410923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric analysis of CD64 expression pattern and density in the diagnosis of acute promyelocytic leukemia: a multi-center study in Shanghai, China.
    Liu M; Weng X; Gong S; Chen H; Ding J; Guo M; Hu X; Wang J; Yang J; Tang G
    Oncotarget; 2017 Oct; 8(46):80625-80637. PubMed ID: 29113330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia.
    Ruhnke L; Stölzel F; Wagenführ L; Altmann H; Platzbecker U; Herold S; Rump A; Schröck E; Bornhäuser M; Schetelig J; von Bonin M
    Front Oncol; 2021; 11():666014. PubMed ID: 33937079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypes and immune markers associated with acute promyelocytic leukemia prognosis.
    Xu F; Yin CX; Wang CL; Jiang XJ; Jiang L; Wang ZX; Yi ZS; Huang KK; Meng FY
    Dis Markers; 2014; 2014():421906. PubMed ID: 25045197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of autofluorescence as a diagnostic feature of acute promyelocytic leukemia.
    Hayden PJ; O'Connell NM; O'Brien DA; O'Rourke P; Lawlor E; Browne PV
    Haematologica; 2006 Mar; 91(3):417-8. PubMed ID: 16531269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.